mrunali more’s Post

🌬️ 𝐀𝐬𝐭𝐡𝐦𝐚 𝐓𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭 𝐃𝐞𝐯𝐢𝐜𝐞𝐬 𝐌𝐚𝐫𝐤𝐞𝐭: 𝐁𝐫𝐞𝐚𝐭𝐡𝐢𝐧𝐠 𝐍𝐞𝐰 𝐋𝐢𝐟𝐞 𝐢𝐧𝐭𝐨 𝐑𝐞𝐬𝐩𝐢𝐫𝐚𝐭𝐨𝐫𝐲 𝐂𝐚𝐫𝐞 🌿 The Asthma Treatment Devices Market focuses on devices designed to manage asthma symptoms, alleviate airway constriction, and improve overall respiratory function. Key product categories include inhalers, nebulizers, and other respiratory devices, which serve patients in both clinical and homecare settings. Asthma remains a prevalent respiratory disorder, affecting millions globally, with its incidence rising due to factors like pollution, urbanization, and lifestyle changes. The market for asthma treatment devices has grown in response to these needs, and advancements in device technology have driven greater efficacy and user adherence. 𝐂𝐥𝐢𝐜𝐤 𝐇𝐞𝐫𝐞, 𝐓𝐨 𝐆𝐞𝐭 𝐅𝐫𝐞𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 https://lnkd.in/g8mSTVam #Company AstraZeneca GlaxoSmithKline Philips Omron 3M Drive DeVilbiss Healthcare #Type Nebulizers Inhalers #Applications Hospitals Clinics Home Care Others 𝐊𝐞𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐃𝐫𝐢𝐯𝐞𝐫𝐬 Growing Prevalence of Asthma and Respiratory Disorders: The rising number of asthma cases, particularly among children and older adults, has increased the demand for effective and accessible treatment devices. Advances in Inhaler Technology: Innovations like smart inhalers and breath-actuated inhalers are improving patient adherence and tracking treatment efficacy, contributing to increased device adoption. Increased Air Pollution and Urbanization: Higher pollution levels, especially in urban areas of developing nations, are linked to an uptick in asthma and other respiratory conditions, spurring demand for management solutions. Patient Preference for Homecare Devices: With more patients preferring homecare options, portable and easy-to-use asthma devices like inhalers and nebulizers have become essential in managing symptoms outside of clinical settings. 𝐂𝐥𝐢𝐜𝐤 𝐇𝐞𝐫𝐞, 𝐓𝐨 𝐁𝐮𝐲 𝐏𝐫𝐞𝐦𝐢𝐮𝐦 𝐑𝐞𝐩𝐨𝐫𝐭 https://lnkd.in/giqdKQ8J #Asthma #RespiratoryCare #Inhalers #HealthcareInnovation #PatientCare #MedicalDevices #Pulmonology #DigitalHealth #AsthmaAwareness #ChronicDiseaseManagement

The India Respiratory Monitoring Market has been valued at USD 752.11 Million in 2023 and is expected to witness remarkable growth, with a CAGR of 7.04% from 2023 to 2029. This essential healthcare sector is transforming the way respiratory health is monitored and managed, offering new opportunities to improve patient care and outcomes. Respiratory monitoring plays a critical role in assessing and tracking breathing patterns to ensure optimal lung function. It helps detect respiratory complications early, especially in critical care units, surgical settings, and chronic disease management. The rise in respiratory disorders, advances in monitoring technologies, and increasing applications in home care settings are driving the market forward. These systems utilize sophisticated tools like spirometers, oximeters, and capnographs to deliver precise, real-time insights into respiratory health. Notably, the growing focus on CPAP devices and advancements in research & development are key market drivers. However, regions like North India, particularly Delhi, face major challenges due to severe air pollution, making the need for effective respiratory monitoring more critical than ever. Report in PDF with chart and Figures - https://lnkd.in/gAewH5Uq Report Description - https://lnkd.in/gSFypuka Key Market Players in the Indian respiratory monitoring market include: Philips India Ltd DeVilbiss Healthcare Pvt Ltd ResMed India GSK India Medtronic Pvt. Ltd. Fisher & Paykel Healthcare India Pvt Ltd Getinge Medical India Pvt Ltd MASIMO MEDICAL TECHNOLOGIES INDIA PRIVATE LIMITED As the market continues to evolve, advanced respiratory monitoring technologies will play an even more significant role in enhancing patient safety and improving overall healthcare outcomes. #Healthcare #RespiratoryMonitoring #MedicalTechnology #IndiaMarket #PatientCare #Innovation #AirPollution #MedicalDevices #HealthcareTechnology #CAGR

𝐓𝐡𝐞 𝐑𝐨𝐥𝐞 𝐨𝐟 𝐒𝐩𝐢𝐫𝐨𝐦𝐞𝐭𝐞𝐫 𝐀𝐩𝐩𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧𝐬 𝐢𝐧 𝐂𝐎𝐏𝐃 𝐚𝐧𝐝 𝐀𝐬𝐭𝐡𝐦𝐚 𝐌𝐚𝐧𝐚𝐠𝐞𝐦𝐞𝐧𝐭 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐅𝐫𝐞𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭@https://lnkd.in/d9MkhcRr In recent years, the integration of technology in healthcare has transformed patient management, especially for chronic respiratory conditions like Chronic Obstructive Pulmonary Disease (COPD) and Asthma. 🔍 What is a Spirometer? A spirometer is a vital tool that measures lung function by assessing the volume and speed of air that can be inhaled and exhaled. Its applications are crucial for monitoring and managing respiratory diseases. 💡 Key Benefits of Spirometer Applications: Early detection of abnormal lung function allows for timely interventions. Personalized care helps track individual patient progress and adjust treatment plans based on real-time data. Patient empowerment encourages individuals to take an active role in their health by monitoring lung function. Data integration seamlessly connects with electronic health records (EHRs) for comprehensive patient insights. 🌟 Impact on COPD and Asthma Management: For COPD, regular spirometry helps manage exacerbations, improve quality of life, and reduce hospital admissions. In asthma management, it enables patients and healthcare providers to identify triggers and optimize medication use for better control. 🛠️ Innovations in Spirometry: With advancements in mobile health applications, spirometry can now be performed easily at home, offering convenience and continuous monitoring for patients. 📈 The Future of Respiratory Care: As we look ahead, the combination of spirometry and telehealth presents exciting opportunities for improving outcomes for patients with COPD and asthma. Let's harness the power of technology to breathe easier! #RespiratoryHealth #Spirometry #COPD #Asthma #HealthcareInnovation #PatientCare #Telehealth

Gain insights into the factors driving the global ventilators market! The global ventilators market, valued at USD 1.75 Billion in 2023, is expected to reach USD 2.56 Billion by 2029, growing at a CAGR of 6.50%. The significant growth is primarily propelled by the rising prevalence of COPD and other respiratory disorders, alongside the influence of the COVID-19 pandemic. Technological advancements have resulted in the creation of advanced portable ventilators, improving patient care both in hospital and home environments. Market growth is expected to be driven by the demand for ICU treatment and ventilation support, particularly as pediatric patients in ICUs/PICUs often require mechanical ventilation for respiratory illnesses. Latin America, the Middle East and Africa are developing markets with increasing medical needs and healthcare infrastructure developments. Invasive ventilators dominated the market share, primarily due to factors such as the growing elderly population and the escalation of chronic respiratory conditions necessitating invasive ventilation, thereby propelling market growth in this segment. The hospital segment is expected to cross $1 billion by 2029. Ventilators are the most vital part of hospitals due to the increasing demand for critical care services from hospitals. The market's competitive landscape is defined by key global players focusing on product innovation and expansion strategies to meet growth. Hamilton Medical, ResMed, Medtronic, and GE HealthCare are some of the leading players currently dominating the global ventilators market. Know more https://lnkd.in/g6e4C3YP #globalventilatorsmarket #ventilatorsmarket #ariztonresearchreveals #focusreportsbyarizton #marketresearch #researchreport #marketinsights #markettrends #marketsize #marketshare #marketgrowth #marketforecast #marketexpansion #marketdemand #healthcare #lifesciences #healthcareandlifesciences #healthcareindustry

𝐌𝐮𝐜𝐮𝐬 𝐂𝐥𝐞𝐚𝐫𝐚𝐧𝐜𝐞 𝐃𝐞𝐯𝐢𝐜𝐞𝐬 𝐟𝐨𝐫 𝐂𝐎𝐏𝐃 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐩𝐨𝐫𝐭: 𝐄𝐧𝐡𝐚𝐧𝐜𝐢𝐧𝐠 𝐑𝐞𝐬𝐩𝐢𝐫𝐚𝐭𝐨𝐫𝐲 𝐇𝐞𝐚𝐥𝐭𝐡 𝐚𝐧𝐝 𝐐𝐮𝐚𝐥𝐢𝐭𝐲 𝐨𝐟 𝐋𝐢𝐟𝐞 𝐂𝐥𝐢𝐜𝐤 𝐇𝐞𝐫𝐞, 𝐓𝐨 𝐆𝐞𝐭 𝐅𝐫𝐞𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 https://lnkd.in/eX6rA_ki The mucus clearance devices market for Chronic Obstructive Pulmonary Disease (COPD) is experiencing growth as the global prevalence of respiratory diseases rises. These devices are essential in helping patients with COPD and other pulmonary conditions clear mucus from the lungs, enhancing breathing, reducing infections, and improving quality of life. Advancements in technology, including oscillatory positive expiratory pressure (OPEP) devices, high-frequency chest wall oscillation (HFCWO) systems, and portable solutions, are expanding options for effective at-home care. Market Trends: Increasing Prevalence of COPD and Respiratory Disorders: Rising cases of COPD and awareness of respiratory health are driving demand for advanced mucus clearance devices. Shift Toward Home Care Solutions: Portable and user-friendly devices are gaining popularity as they empower patients to manage symptoms independently and avoid hospital visits. Technological Advancements in Device Efficiency: Innovations in oscillatory and chest wall oscillation technologies are improving mucus clearance and patient comfort. Focus on Preventative Care and Improved Quality of Life: Patients and healthcare providers are increasingly adopting devices that support long-term management of COPD and reduce exacerbations. Growth in Telemedicine Integration: Some devices now incorporate digital monitoring, allowing healthcare providers to track respiratory health remotely, which is especially valuable for chronic conditions like COPD. #Company Hillrom Allergan Respiratory Health Technologies Smiths Medical Electromed, Inc. Monaghan Medical Corporation Thayer Medical Corporation VORTRAN Medical Technology 1, Inc. #Type HFCWO Devices OPEP Devices MCA Devices IPV Devices PEP Devices #Applications Homecare Settings Hospitals 𝐂𝐥𝐢𝐜𝐤 𝐇𝐞𝐫𝐞, 𝐓𝐨 𝐁𝐮𝐲 𝐏𝐫𝐞𝐦𝐢𝐮𝐦 𝐑𝐞𝐩𝐨𝐫𝐭 https://lnkd.in/ejiguvKs #COPDTreatment #MucusClearance #RespiratoryHealth #PulmonaryCare #HomeHealthcare #COPDManagement #ChronicRespiratoryDisease #PatientCare #InnovativeDevices #RespiratoryTherapy

🌟 𝐁𝐫𝐞𝐚𝐭𝐡𝐢𝐧𝐠 𝐄𝐚𝐬𝐢𝐞𝐫: 𝐄𝐱𝐩𝐥𝐨𝐫𝐢𝐧𝐠 𝐭𝐡𝐞 𝐀𝐬𝐭𝐡𝐦𝐚 𝐂𝐚𝐫𝐞 𝐄𝐪𝐮𝐢𝐩𝐦𝐞𝐧𝐭 𝐌𝐚𝐫𝐤𝐞𝐭! 🌟 𝐂𝐥𝐢𝐜𝐤 𝐇𝐞𝐫𝐞, 𝐓𝐨 𝐆𝐞𝐭 𝐅𝐫𝐞𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 https://lnkd.in/gR9VDaXm Asthma care equipment encompasses a range of devices designed to monitor, manage, and treat asthma, a chronic respiratory condition affecting millions worldwide. These tools play a crucial role in helping patients maintain control over their symptoms and prevent asthma exacerbations. 🔬 Key Highlights: Inhalers and Nebulizers: Inhalers and nebulizers are fundamental devices in asthma management. Inhalers, including metered-dose inhalers (MDIs) and dry powder inhalers (DPIs), deliver medication directly to the lungs, providing quick relief from asthma symptoms. Nebulizers convert liquid medication into a fine mist, making it easier for patients, especially young children and the elderly, to inhale the medication. Peak Flow Meters: Peak flow meters are handheld devices used to measure a patient’s peak expiratory flow rate (PEFR), an indicator of lung function. Regular monitoring with peak flow meters helps patients track their asthma control, detect early signs of exacerbation, and adjust their treatment plan accordingly. Spirometers: Spirometers are diagnostic tools used to assess lung function by measuring the volume and speed of air exhaled. They are essential for diagnosing asthma, evaluating its severity, and monitoring lung function over time. Portable spirometers allow for convenient home monitoring, enhancing patient engagement and adherence to treatment. Smart Inhalers: Smart inhalers are equipped with digital sensors that track medication usage and provide real-time data to patients and healthcare providers. These devices offer reminders, adherence tracking, and personalized feedback, helping patients stick to their prescribed treatment regimen and improve asthma management. #Company Respiri Limited Volansys Technologies Vitalograph Health Care Originals Microlife AG OMRON Healthcare EMEA Quvium UK Adherium National Jewish Health Aerogen Pari #Type Nebulizers Aerosol Spacers Lung Trainers Asthma Monitoring Devices #Application Hospitals & Clinics Home Care #AsthmaCare #RespiratoryHealth #Inhalers #SmartInhalers #Nebulizers #PeakFlowMeters #Spirometers #DigitalHealth #Telemedicine #HealthcareInnovation #PatientCare #AsthmaManagement #MedicalDevices

Ventilators Market Worth $5.7 Billion by 2028, growing at a CAGR of 6.4% Download PDF Brochure:-https://lnkd.in/dn7wR4np Ventilators Market in terms of revenue was estimated to be worth $4.2 Billion in 2023 and is poised to reach $5.7 Billion by 2028, growing at a CAGR of 6.4% from 2023 to 2028 according to a new report by MarketsandMarkets™. The growth of the global ventilators market is driven by the rising burden of #respiratory #diseases, such as #COPD and #asthma. COPD and asthma result in the narrowing of respiratory paths, making breathing difficults. Therefore, many patirnts with COPD and asthma require external ventilation and airway management which will dive growth for #ventilators market. However, skilled workforce shortages have been exacerbated during the pandemic and can hamper the growth of the ventilators market in the coming years. #ventilators #respiratorycare #criticalcare #medicaldevices #healthtech #ventilatorshortage #lifesupport #intensivecare #ventilationequipment #hospitalequipment #patientcare #emergencymedicine #healthcaretechnology #pulmonarycare #icumanagement #respiratorytherapy #mechanicalventilation #patientmonitoring #ventilatorsupply #healthcareinnovation #hospitals #marketresearch #marketshare #marketgrowth #marketsize

Preventive health care is at the core of #valuebasedcare. Preventive strategies, of course, encompass many things, from screenings for conditions like colorectal cancer, to exercise, nutrition and habits that contribute to overall vitality. As doctors, we should embrace and encourage all of them given their direct impact on patient health. But value-based approaches and the preventive measures and actions that are directly linked to them also contribute meaningful, and often transformative improvements to the business of #healthcare. At @CareAllies, we are privileged to see just how impactful preventive measures are on both fronts – witnessing firsthand the singular impact they have on patient health outcomes as well as the practices, hospitals and health systems that encourage them. At its core, this is why #valuebasedcare represents such a win-win for all involved, and for our great nation. https://lnkd.in/ga6VhKQD News Medical

Report: Indian Society of Lifestyle Medicine Joins Hands with Healthy India Alliance The Indian Society of Lifestyle Medicine (ISLM) has officially joined the Healthy India Alliance (HIA), marking a significant step forward in the country's efforts to combat non-communicable diseases (NCDs) and promote preventive healthcare. This collaboration between ISLM, a leading advocate for lifestyle-based interventions, and HIA, a national network committed to strengthening public health, is poised to create a more comprehensive approach to health policy development in India. The partnership is expected to amplify the focus on lifestyle medicine, which emphasizes diet, physical activity, stress management, and behavior modification as critical components in preventing and managing NCDs such as diabetes, cardiovascular diseases, and hypertension. By leveraging the expertise of both organizations, this alliance will play a pivotal role in influencing health policies aimed at reducing the burden of NCDs and improving the overall health and well-being of the Indian population. As the prevalence of NCDs continues to rise, this collaboration comes at a crucial time, positioning ISLM and HIA to drive policy changes that prioritize sustainable, preventive healthcare models. Their joint efforts are anticipated to not only shape public health strategies but also raise awareness and foster a culture of healthy living across India. https://lnkd.in/gMaWxZp3

COPD (chronic obstructive pulmonary disease) is one of the leading causes of death and hospitalizations globally and in the UK. Remote monitoring of COPD relies on using various devices such as pulse oximeters, inhalers and various apps with the aim of helping patients manage their condition in the comfort of their own home and preventing deterioration in health. However, evidence is lacking on how best to implement remote monitoring so that it helps patients, reduces inequalities in health outcomes for patients and supports decision-making bodies such as NHS England in preparing for increased demands for health care services in winter. As part of the new NIHR (National Institute for Health and Care Research) DECIDE Centre for rapid evaluation, RAND Europe, together with the Nuffield Department of Primary Care Health Sciences - University of Oxford, will consider what works, how, why and when in remote monitoring for COPD patients to help provide evidence that can inform the best possible decisions for patient care. Find out more: https://lnkd.in/eMa-ER6E #NHS #COPD #Pulmonology #HealthTechnology #Evaluation #DigitalHealth